These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 30134449)

  • 21. Use of DOAC Stop for elimination of anticoagulants in the thrombin generation assay.
    Kopatz WF; Brinkman HJM; Meijers JCM
    Thromb Res; 2018 Oct; 170():97-101. PubMed ID: 30149286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Measurement of the new anticoagulants.
    Harenberg J; Kraemer R
    Thromb Res; 2012 Apr; 129 Suppl 1():S106-13. PubMed ID: 22682119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A retrospective study of indications and consequences of monitoring direct oral anticoagulant plasma concentrations on patient care in a university hospital: The Retro-AOD study.
    Cavaillez T; Weinmann L; Mouton C; Delassasseigne C; Sesay M; Biais M; James C; Roullet S
    Thromb Res; 2021 Oct; 206():76-83. PubMed ID: 34419866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors of pre-procedural concentrations of direct oral anticoagulants: a prospective multicentre study.
    Godier A; Dincq AS; Martin AC; Radu A; Leblanc I; Antona M; Vasse M; Golmard JL; Mullier F; Gouin-Thibault I
    Eur Heart J; 2017 Aug; 38(31):2431-2439. PubMed ID: 28821169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Testing and monitoring direct oral anticoagulants.
    Connors JM
    Blood; 2018 Nov; 132(19):2009-2015. PubMed ID: 30201757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interference of DOACs in different DRVVT assays for diagnosis of lupus anticoagulants.
    Flieder T; Weiser M; Eller T; Dittrich M; von Bargen K; Alban S; Kuhn J; Knabbe C; Birschmann I
    Thromb Res; 2018 May; 165():101-106. PubMed ID: 29627719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Direct oral anticoagulant (DOAC) interference in hemostasis assays.
    Moser KA; Smock KJ
    Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):129-133. PubMed ID: 34889400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Point-of-Care Coagulation Tests Monitoring of Direct Oral Anticoagulants and Their Reversal Therapy: State of the Art.
    Iapichino GE; Bianchi P; Ranucci M; Baryshnikova E
    Semin Thromb Hemost; 2017 Jun; 43(4):423-432. PubMed ID: 28346965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Direct Oral Anticoagulant Agents: Pharmacologic Profile, Indications, Coagulation Monitoring, and Reversal Agents.
    Rose DK; Bar B
    J Stroke Cerebrovasc Dis; 2018 Aug; 27(8):2049-2058. PubMed ID: 29753603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Laboratory coagulation tests in patients treated by direct oral anticoagulants (DOACs)].
    Sié P
    Presse Med; 2015; 44(7-8):772-8. PubMed ID: 26248706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Laboratory Assessment of the Anticoagulant Activity of Direct Oral Anticoagulants: A Systematic Review.
    Samuelson BT; Cuker A; Siegal DM; Crowther M; Garcia DA
    Chest; 2017 Jan; 151(1):127-138. PubMed ID: 27637548
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: proposals of the working group on perioperative haemostasis (GIHP) - March 2013.
    Pernod G; Albaladejo P; Godier A; Samama CM; Susen S; Gruel Y; Blais N; Fontana P; Cohen A; Llau JV; Rosencher N; Schved JF; de Maistre E; Samama MM; Mismetti P; Sié P;
    Arch Cardiovasc Dis; 2013; 106(6-7):382-93. PubMed ID: 23810130
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simple method for removing DOACs from plasma samples.
    Exner T; Michalopoulos N; Pearce J; Xavier R; Ahuja M
    Thromb Res; 2018 Mar; 163():117-122. PubMed ID: 29407622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reversal of direct oral anticoagulants: a practical approach.
    Shih AW; Crowther MA
    Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):612-619. PubMed ID: 27913536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct oral anticoagulants: new drugs and new concepts.
    Levy JH; Spyropoulos AC; Samama CM; Douketis J
    JACC Cardiovasc Interv; 2014 Dec; 7(12):1333-51. PubMed ID: 25523529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Laboratory Assessment of Direct Oral Anticoagulants.
    Douxfils J; Gosselin RC
    Semin Thromb Hemost; 2017 Apr; 43(3):277-290. PubMed ID: 28249326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapid point-of-care detection and classification of direct-acting oral anticoagulants with the TEG 6s: Implications for trauma and acute care surgery.
    Dias JD; Lopez-Espina CG; Ippolito J; Hsiao LH; Zaman F; Muresan AA; Thomas SG; Walsh M; Jones AJ; Grisoli A; Thurston BC; Artang R; Bilden KP; Hartmann J; Achneck HE
    J Trauma Acute Care Surg; 2019 Aug; 87(2):364-370. PubMed ID: 31045726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An optimized dRVVT-based assay to estimate the intensity of anticoagulation in patients treated with direct oral anticoagulants.
    Sennesael AL; Exner T; Chatelain B; Lessire S; Larock AS; Vancraeynest C; Pochet L; Dogné JM; Spinewine A; Mullier F; Douxfils J
    Thromb Res; 2017 Sep; 157():29-37. PubMed ID: 28686914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Direct oral anticoagulants and heparins: laboratory values and pitfalls in 'bridging therapy'.
    Eller T; Flieder T; Fox V; Gripp T; Dittrich M; Kuhn J; Alban S; Knabbe C; Birschmann I
    Eur J Cardiothorac Surg; 2017 Apr; 51(4):624-632. PubMed ID: 28043992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening test for direct oral anticoagulants with the dilute Russell viper venom time.
    Pratt J; Crispin P
    Eur J Haematol; 2018 Jun; 100(6):567-574. PubMed ID: 29486103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.